Sema4 is the developer of an AI-driven patient-centered genomic and clinical data insight platform designed to to transform healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology.
SMFR
0.3106 as of 1/9/23
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 7/29/2020 | Series C | $1.47B | $XXX.XX | $XXX.XX |
| 8/22/2019 | Series B | $577.68MM | $XXX.XX | $XXX.XX |
| 3/21/2018 | Series A-1 and A-2 | $145.93MM | $XXX.XX | $XXX.XX |
